REVBW logo

Revelation Biosciences, Inc. (REVBW)

Profile

Full Name

Revelation Biosciences, Inc.

Ticker

NASDAQ: REVBW

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://www.revbiosciences.com

Employees

8

Key Details

Price

$0.02(-1.27%)

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.02
    REVBW price is $0.02

    30-Day Relative Volume

    0.87
    REVBW 30-day relative volume is 0.87

    Price Performance

    Price Most recent change

    -1.27%
    REVBW price was down -1.27% on Jul 28, 2025

    Price YTD change

    +121.43%
    REVBW price is up +121.43% since January 1st

    Price 1-year change

    +22.05%
    REVBW price is up +22.05% year-on-year

    Price 3-year change

    -
    REVBW price 3-year change is unknown

    Price Range

    Price All-time high

    $0.12
    REVBW price is currently -87.05% below its historical high of $0.12

    Price 3-year low

    $0.00
    REVBW price is currently +236.96% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    REVBW market capitalization value is unknown

    Market cap 3-year change

    -
    REVBW market capitalization 3-year change is unknown

    Market cap All-time high

    -
    REVBW market capitalization all-time high is unknown

    Market cap sector rank

    -
    REVBW market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    REVBW shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    REVBW shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.46
    REVBW beta is -0.46

    200-day SMA

    $0.01
    REVBW price is currently +21.09% above its 200-day simple moving average

    50-day SMA

    $0.01
    REVBW price is currently +29.17% above its 50-day simple moving average

    RSI

    50.00
    REVBW 14-day relative strength index is 50.00

    Volume

    0.87
    REVBW 30-day relative volume is 0.87

    ATR

    $0.00
    REVBW average true range is $0.00

    10-day Historical Volatility

    219.92%
    REVBW 10-day historical volatility is 219.92%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    REVBW annual revenue is $0.00

    Revenue Analysts estimate

    -
    REVBW annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    REVBW annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    1.14%
    REVBW annual revenue is higher than 1.14% of companies in Healthcare sector

    EPS

    EPS

    -
    REVBW annual earnings per share value is unknown

    EPS Analysts estimate

    -
    REVBW annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -
    REVBW annual earnings per share 1-year change is unknown

    EPS Sector rank

    -
    REVBW annual earnings per share is unknown

    Profit

    Gross profit

    -
    REVBW annual gross profit value is unknown

    Gross margin

    -
    REVBW annual gross profit margin value is unknown

    Operating profit

    -$7.98M
    REVBW annual operating income is -$7.98 million

    Operating margin

    -
    REVBW annual operating profit margin value is unknown

    Net income

    -$15.04M
    REVBW annual net profit is -$15.04 million

    Net margin

    -
    REVBW annual net profit margin value is unknown

    Expenses

    Total expenses

    $7.98M
    REVBW annual total expenses is $7.98 million

    Operating expenses

    $7.98M
    REVBW annual total operating expenses is $7.98 million

    Cost of goods sold

    -
    REVBW annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $4.43M
    REVBW annual SGA is $4.43 million

    Depreciation and amortization

    $27.92K
    REVBW annual depreciation & amortization is $27.92 thousand

    Interest expense

    -
    REVBW annual interest expense value is unknown

    Income tax

    -
    REVBW annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$7.98M
    REVBW annual earnings before interest & taxes is -$7.98 million

    EBITDA

    -$8.03M
    REVBW annual EBITDA is -$8.03 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $6.62M
    REVBW annual total assets is $6.62 million

    Non current assets

    $56.33K
    REVBW annual long term assets is $56.33 thousand

    Current assets

    $6.57M
    REVBW annual total current assets is $6.57 million

    Cash and cash equivalents

    $6.50M
    REVBW annual cash & cash equivalents is $6.50 million

    Accounts receivable

    -
    REVBW annual accounts receivable value is unknown

    Inventory

    -
    REVBW annual inventory value is unknown

    Liabilities

    Total liabilities

    $1.91M
    REVBW annual total liabilities is $1.91 million

    Long term liabilities

    $0.00
    REVBW annual total long term liabilities is $0.00

    Current liabilities

    $1.91M
    REVBW annual total current liabilities is $1.91 million

    Accounts payable

    $783.62K
    REVBW annual accounts payable is $783.62 thousand

    Debt

    Total debt

    -
    REVBW annual total debt value is unknown

    Total debt 1-year change

    -
    REVBW annual total debt 1-year change is unknown

    Long term debt

    -
    REVBW annual long term debt value is unknown

    Short term debt

    -
    REVBW annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $4.71M
    REVBW annual stockholders equity is $4.71 million

    Book value

    $4.71M
    REVBW annual book value is $4.71 million

    Retained earnings

    -$40.51M
    REVBW annual retained earnings is -$40.51 million

    Working capital

    $4.65M
    REVBW annual working capital is $4.65 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$18.32M
    REVBW annual cash flow from operations is -$18.32 million

    Cash from operations 1-year change

    -151.45%
    REVBW annual cash flow from operations is down -151.45% year-on-year

    Cash from investing

    -$19.17K
    REVBW annual cash flow from investing activities is -$19.17 thousand

    Cash from investing 1-year change

    -100%
    REVBW annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $12.85M
    REVBW annual cash flow from financing activities is $12.85 million

    Cash from financing 1-year change

    -8.39%
    REVBW annual cash flow from financing activities is down -8.39% year-on-year

    CAPEX

    CAPEX

    $19.17K
    REVBW annual capital expenditures is $19.17 thousand

    CAPEX 1-year change

    -
    REVBW annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$18.34M
    REVBW annual free cash flow is -$18.34 million

    Free cash flow 1-year change

    -151.71%
    REVBW annual free cash flow is down -151.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    REVBW annual gross profit margin value is unknown

    Operating margin

    -
    REVBW annual operating profit margin value is unknown

    Net margin

    -
    REVBW annual net profit margin value is unknown

    ROA & ROE

    ROA

    -227.10%
    REVBW annual return on assets is -227.10%

    ROE

    -319.40%
    REVBW annual return on equity is -319.40%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    REVBW price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    REVBW price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    REVBW price to book ratio value is unknown

    PB ratio Sector rank

    -
    REVBW price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    REVBW price to sales ratio value is unknown

    PS ratio Sector rank

    -
    REVBW price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    REVBW enterprise value value is unknown

    Enterprise value Sector rank

    -
    REVBW enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    REVBW EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    REVBW EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.43
    REVBW annual current ratio is 3.43

    Quick ratio

    -
    REVBW annual quick ratio value is unknown

    Leverage

    Debt to equity

    -
    REVBW annual debt to equity ratio value is unknown

    Interest coverage ratio

    -
    REVBW annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    REVBW piotroski f-score value is unknown

    Altman Z-Score

    -
    REVBW altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with REVBW included

    Stocks cheaper than 1 dollar
    US stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Best performing stocks YTD
    Ex Dividend dates calendar
    • What is the ticker symbol for Revelation Biosciences, Inc.?
    • Does Revelation Biosciences, Inc. pay dividends?
    • What sector is Revelation Biosciences, Inc. in?
    • What industry is Revelation Biosciences, Inc. in?
    • What country is Revelation Biosciences, Inc. based in?
    • Is Revelation Biosciences, Inc. in the S&P 500?
    • Is Revelation Biosciences, Inc. in the NASDAQ 100?
    • Is Revelation Biosciences, Inc. in the Dow Jones?
    • When does Revelation Biosciences, Inc. report earnings?

    What is the ticker symbol for Revelation Biosciences, Inc.?

    The ticker symbol for Revelation Biosciences, Inc. is NASDAQ:REVBW

    Does Revelation Biosciences, Inc. pay dividends?

    No, Revelation Biosciences, Inc. does not pay dividends

    What sector is Revelation Biosciences, Inc. in?

    Revelation Biosciences, Inc. is in the Healthcare sector

    What industry is Revelation Biosciences, Inc. in?

    Revelation Biosciences, Inc. is in the Biotechnology industry

    What country is Revelation Biosciences, Inc. based in?

    Revelation Biosciences, Inc. is headquartered in United States

    Is Revelation Biosciences, Inc. in the S&P 500?

    No, Revelation Biosciences, Inc. is not included in the S&P 500 index

    Is Revelation Biosciences, Inc. in the NASDAQ 100?

    No, Revelation Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Revelation Biosciences, Inc. in the Dow Jones?

    No, Revelation Biosciences, Inc. is not included in the Dow Jones index

    When does Revelation Biosciences, Inc. report earnings?

    The date for Revelation Biosciences, Inc.'s next earnings report has not been announced yet
    On this page